Piramal's Healthcare vertical today announced that it is to invest USD 2.5 million at its FDA approved Grangemouth (UK) site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites, from clinical phase to commercial grade.
Grangemouth, Scotland, UK - Piramal's Healthcare vertical today announced that it is to invest USD 2.5 million at its FDA approved Grangemouth, UK, si ...
Satisfied Users & 
Approved Press Releases
